Clay Siegall has always had a strong interest in medicine, and he believes that modern medicine along with technology can help to give health back to people whose fates once looked grim. His interest in treating cancer began during his days at college when he was pursuing a degree in Zoology. At that time, he had watched a family member go through a horrifying cancer treatment regimen that left them with anemia and almost killed them. Siegall began to look into other cancer treatments that were just as bad, and this is when he realized that he would search to find a better way to treat the disease that takes so many lives. Clay Siegall has learned to couple his passion for treating cancer with his need to make money and pay his bills. His second reason for starting Seattle Genetics was that he didn’t feel like he had the freedom to work on his projects as he liked. His company now makes money by selling its own drugs and through production partnerships.
Clay Siegall is the founder of Seattle Genetics, and he serves the company as its CEO, President, and Chairman of the Board. He has been trained as a scientist that specializes in therapies that are targeted at cancer. His hope for starting Seattle Genetics in 1998 was to help as many people as possible, and through his company, he has managed to get FDA approval for an antibody-drug-conjugates product named ADCETRIS. The drug has been approved for use in over 65 countries.
Clay Siegall earned his Bachelor’s of Science Degree in Zoology while studying at the University of Maryland, and he went on to work for his Ph.D. in Genetics, which he received from George Washington University. He has 15 patents under his belt and is an author that has put out over 70 different publications. Currently, Siegall sits on the Boards of Directors for a spread of organizations including Washington Roundtable, Ultragenyx Pharmaceutical, and Alder BioPharmaceuticals. He has won countless awards that include the 2013 University of Maryland Alumnus of the Year for Computer and the 2012 Pacific Northwest Ernst & Young Entrepreneur of the Year.